Scottish researchers use video games to treat amblyopia

Article

Researchers at Glasgow Caledonian University (GCU) are developing a way to use video games to improve the eyesight of children with amblyopia.

Glasgow, Scottland-Researchers at Glasgow Caledonian University (GCU) are developing a way to use video games to improve the eyesight of children with amblyopia

While children with amblyopia are currently treated with patching, the researchers believe there is potential for greater motivation and engagement through the use of video games, which stimulate both eyes, improving both visual acuity and stereo vision.

Vision therapy: A top 10 must-have list

Through a grant from the Chief Scientist Office, the researchers at GCU are developing a custom video game in collaboration with the University of California, Berkeley, which will split the screen to encourage the use of both eyes. Professor Anita Simmers used this approach in a study where children wore gaming goggles to play a Tetris-style game for an hour a day over seven to 10 days. The study established the feasibility of a perceptual learning approach to amblyopia with improvements in both visual acuity and stereo vision.

“My belief is that, while an eye patch works up to a point, there can be further improvements to vision in children of an older age-say six or seven- through greater motivation and engagement with a video task. Encouraging the use of both eyes in a treatment is a fundamentally different approach,” says Professor Simmers. 

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.